Canaccord Says Sell NuVasive On Deal Speculation Rally, Buy Smith & Nephew

The analyst does not find a potential of NuVasive acquisition by Smith & Nephew "to be compelling". A deal could be disruptive to Smith & Nephew's turnaround in both commercial performance and investor sentiment.